These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32181932)

  • 1. Expression, location and biological effects of four and a half LIM domain protein 2 (FHL2) on granulosa cells in ovine.
    Zhang L; Li R; Chen L; Xing Z; Song Y; Nie X; Wang L; Han H; Liu A; Ma X; Ma RZ; Tian S
    Reprod Domest Anim; 2020 Jun; 55(6):737-746. PubMed ID: 32181932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHL2 deficiency impairs follicular development and fertility by attenuating EGF/EGFR/YAP signaling in ovarian granulosa cells.
    Wang C; Sun H; Davis JS; Wang X; Huo L; Sun N; Huang Q; Lv X; Wang C; He C; He C; Zhou Y; Wu J; Yang L; Hua G
    Cell Death Dis; 2023 Apr; 14(4):239. PubMed ID: 37015904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
    Matulis CK; Mayo KE
    Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
    Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
    Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis.
    Wang C; Lv X; He C; Davis JS; Wang C; Hua G
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle Cell.
    Liu Z; Han S; Wang Y; Cui C; Zhu Q; Jiang X; Yang C; Du H; Yu C; Li Q; He H; Shen X; Chen Y; Zhang Y; Ye L; Zhang Z; Li D; Zhao X; Yin H
    Int J Biol Sci; 2019; 15(4):838-846. PubMed ID: 30906214
    [No Abstract]   [Full Text] [Related]  

  • 10. Up-regulated FHL2 inhibits ovulation through interacting with androgen receptor and ERK1/2 in polycystic ovary syndrome.
    Zhou R; Li S; Liu J; Wu H; Yao G; Sun Y; Chen ZJ; Li W; Du Y
    EBioMedicine; 2020 Feb; 52():102635. PubMed ID: 32028069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
    Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
    J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four and a half LIM domain protein 2 enhances differentiation and mineralization of human dental pulp cells.
    Tian X; Wang Q; Wang X
    J Endod; 2015 Apr; 41(4):513-9. PubMed ID: 25662359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHL2 interacts with iASPP and impacts the biological functions of leukemia cells.
    Lu W; Yu T; Liu S; Li S; Li S; Liu J; Xu Y; Xing H; Tian Z; Tang K; Rao Q; Wang J; Wang M
    Oncotarget; 2017 Jun; 8(25):40885-40895. PubMed ID: 28402264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL2 protein is a novel co-repressor of nuclear receptor Nur77.
    Kurakula K; van der Wal E; Geerts D; van Tiel CM; de Vries CJ
    J Biol Chem; 2011 Dec; 286(52):44336-43. PubMed ID: 22049082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice.
    Huss S; Stellmacher C; Goltz D; Khlistunova I; Adam AC; Trebicka J; Kirfel J; Büttner R; Weiskirchen R
    BMC Gastroenterol; 2013 Jan; 13():8. PubMed ID: 23311569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of FHL2 in cancer.
    Zhang J; Zeng Q; She M
    Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
    Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
    J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FHL2 binds calcineurin and represses pathological cardiac growth.
    Hojayev B; Rothermel BA; Gillette TG; Hill JA
    Mol Cell Biol; 2012 Oct; 32(19):4025-34. PubMed ID: 22851699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FHL2-driven molecular network mediated Septin2 knockdown inducing apoptosis in mesangial cell.
    Lu Y; Cai G; Cui S; Geng W; Chen D; Wen J; Zhang Y; Zhang F; Xie Y; Fu B; Chen X
    Proteomics; 2014 Nov; 14(21-22):2485-97. PubMed ID: 25103794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.
    Li N; Xu L; Zhang J; Liu Y
    Int J Exp Pathol; 2022 Jun; 103(3):90-101. PubMed ID: 35366027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.